| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-282 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-282 |
| filingDate |
2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101916580-B1 |
| titleOfInvention |
Composition for treatment or prevention of liver disease comprising extract of Artemisia capillaris, Sanguisorba officinalis L. and Curcuma longa L. and antiviral agent |
| abstract |
The present invention relates to a composition for the prevention or treatment of liver diseases, which comprises astaxanthin, chaffin, and ganoderma extract and an antiviral agent as an active ingredient. The combined administration of the antiviral agent of the prophylactic, antirheumatic and herbal extracts of the present invention and the hepatitis B virus according to the present invention inhibits the hepatitis B virus e antigen and effectively inhibits the expression of the inflammatory cytokines TNF- ?, IL-1? Or TGF-? In addition to the treatment of hepatitis B, cirrhosis or liver cancer can be expected to be suppressed. |
| priorityDate |
2016-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |